Horizontal transfer of whole mitochondria restores tumorigenic potential in mitochondrial DNA-deficient cancer cells

Abstract

Recently we showed that generation of tumours in syngeneic mice by cells devoid of mitochondrial (mt) DNA (ρ0 cells) is linked to acquisition of the host mtDNA. However, the mechanism of mtDNA movement between cells remains unresolved. To determine whether transfer of mtDNA involves whole mitochondria, we injected B16ρ0 mouse melanoma cells into syngeneic C57BL/6Nsu9-DsRed2 mice that express red fluorescent protein in their mitochondria. We document that mtDNA is acquired by transfer of whole mitochondria from the host animal, leading to normalisation of mitochondrial respiration. Additionally, knockdown of key mitochondrial complex I (NDUFV1) and complex II (SDHC) subunits by shRNA in B16ρ0 cells abolished or significantly retarded their ability to form tumours. Collectively, these results show that intact mitochondria with their mtDNA payload are transferred in the developing tumour, and provide functional evidence for an essential role of oxidative phosphorylation in cancer.

Article and author information

Author details

  1. Lan-Feng Dong

    School of Medical Science, Griffith University, Southport, Australia
    Competing interests
    The authors declare that no competing interests exist.
  2. Jaromira Kovarova

    Institute of Biotechnology, Czech Academy of Sciences, Prague, Czech Republic
    Competing interests
    The authors declare that no competing interests exist.
  3. Martina Bajzikova

    Institute of Biotechnology, Czech Academy of Sciences, Prague, Czech Republic
    Competing interests
    The authors declare that no competing interests exist.
  4. Ayenachew Bezawork-Geleta

    School of Medical Science, Griffith University, Southport, Australia
    Competing interests
    The authors declare that no competing interests exist.
  5. David Svec

    Institute of Biotechnology, Czech Academy of Sciences, Prague, Czech Republic
    Competing interests
    The authors declare that no competing interests exist.
  6. Berwini Endaya

    School of Medical Science, Griffith University, Southport, Australia
    Competing interests
    The authors declare that no competing interests exist.
  7. Karishma Sachaphibulkij

    School of Medical Science, Griffith University, Southport, Australia
    Competing interests
    The authors declare that no competing interests exist.
  8. Ana R Coelho

    Institute of Biotechnology, Czech Academy of Sciences, Prague, Czech Republic
    Competing interests
    The authors declare that no competing interests exist.
  9. Natasa Sebkova

    Institute of Biotechnology, Czech Academy of Sciences, Prague, Czech Republic
    Competing interests
    The authors declare that no competing interests exist.
  10. Anna Ruzickova

    Institute of Biotechnology, Czech Academy of Science, Prague, Czech Republic
    Competing interests
    The authors declare that no competing interests exist.
  11. An S Tan

    Malaghan Institute of Medical Research, Wellington, New Zealand
    Competing interests
    The authors declare that no competing interests exist.
  12. Katarina Kluckova

    Institute of Biotechnology, Czech Academy of Sciences, Prague, Czech Republic
    Competing interests
    The authors declare that no competing interests exist.
  13. Kristyna Judasova

    Institute of Biotechnology, Czech Academy of Science, Prague, Czech Republic
    Competing interests
    The authors declare that no competing interests exist.
  14. Katerina Zamecnikova

    Institute of Biotechnology, Czech Academy of Sciences, Prague, Czech Republic
    Competing interests
    The authors declare that no competing interests exist.
  15. Zuzana Rychtarcikova

    Institute of Biotechnology, Czech Academy of Sciences, Prague, Czech Republic
    Competing interests
    The authors declare that no competing interests exist.
  16. Vinod Gopalan

    School of Medical Science, Griffith University, Southport, Australia
    Competing interests
    The authors declare that no competing interests exist.
  17. Margaryta Sobol

    Institute of Molecular Genetics, Czech Academy of Science, Prague, Czech Republic
    Competing interests
    The authors declare that no competing interests exist.
  18. Bing Yan

    School of Medical Science, Griffith University, Southport, Australia
    Competing interests
    The authors declare that no competing interests exist.
  19. Bijay Pattnaik

    CSIR Institute of Genomics and Integrative Biology, New Delhi, India
    Competing interests
    The authors declare that no competing interests exist.
  20. Naveen Bhatraju

    CSIR Institute of Genomics and Integrative Biology, New Delhi, India
    Competing interests
    The authors declare that no competing interests exist.
  21. Jaroslav Truksa

    Institute of Biotechnology, Czech Academy of Sciences, Prague, Czech Republic
    Competing interests
    The authors declare that no competing interests exist.
  22. Pavel Stopka

    Department of Zoology, Charles University, Prague, Czech Republic
    Competing interests
    The authors declare that no competing interests exist.
  23. Pavel Hozak

    Institute of Molecular Genetics, Czech Academy of Science, Prague, Czech Republic
    Competing interests
    The authors declare that no competing interests exist.
  24. Alfred Lam

    School of Medicine, Griffith University, Southport, Australia
    Competing interests
    The authors declare that no competing interests exist.
  25. Radislav Sedlacek

    Institute of Molecular Genetics, Czech Academy of Sciences, Prague, Czech Republic
    Competing interests
    The authors declare that no competing interests exist.
  26. Paulo Oliveira

    Center for Neuroscience and Cell Biology, University of Coimbra, Cantanhede, Portugal
    Competing interests
    The authors declare that no competing interests exist.
  27. Mikael Kubista

    Institute of Biotechnology, Czech Academy of Sciences, Prague, Czech Republic
    Competing interests
    The authors declare that no competing interests exist.
  28. Anurag Agrawal

    CSIR Institute of Genomics and Integrative Biology, New Delhi, India
    Competing interests
    The authors declare that no competing interests exist.
  29. Katerina Dvorakova-Hortova

    Institute of Biotechnology, Czech Academy of Sciences, Prague, Czech Republic
    Competing interests
    The authors declare that no competing interests exist.
  30. Jakub Rohlena

    Institute of Biotechnology, Czech Academy of Science, Prague, Czech Republic
    Competing interests
    The authors declare that no competing interests exist.
  31. Michael V Berridge

    Malaghan Institute of Medical Research, Wellington, New Zealand
    For correspondence
    mberridge@malaghan.org.nz
    Competing interests
    The authors declare that no competing interests exist.
  32. Jiri Neuzil

    School of Medical Science, Griffith University, Southport, Australia
    For correspondence
    j.neuzil@griffith.edu.au
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2478-2460

Funding

Australian Research Council

  • Jiri Neuzil

Czech Science Foundation

  • Jiri Neuzil

BIOCEV European Regional Development Fund

  • Jiri Neuzil

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the Czech Republic All animal procedures and experimental protocols were approved by the Local Ethics Committee (Animal Ethics Number 18/2015).

Copyright

© 2017, Dong et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 7,714
    views
  • 1,562
    downloads
  • 221
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Lan-Feng Dong
  2. Jaromira Kovarova
  3. Martina Bajzikova
  4. Ayenachew Bezawork-Geleta
  5. David Svec
  6. Berwini Endaya
  7. Karishma Sachaphibulkij
  8. Ana R Coelho
  9. Natasa Sebkova
  10. Anna Ruzickova
  11. An S Tan
  12. Katarina Kluckova
  13. Kristyna Judasova
  14. Katerina Zamecnikova
  15. Zuzana Rychtarcikova
  16. Vinod Gopalan
  17. Margaryta Sobol
  18. Bing Yan
  19. Bijay Pattnaik
  20. Naveen Bhatraju
  21. Jaroslav Truksa
  22. Pavel Stopka
  23. Pavel Hozak
  24. Alfred Lam
  25. Radislav Sedlacek
  26. Paulo Oliveira
  27. Mikael Kubista
  28. Anurag Agrawal
  29. Katerina Dvorakova-Hortova
  30. Jakub Rohlena
  31. Michael V Berridge
  32. Jiri Neuzil
(2017)
Horizontal transfer of whole mitochondria restores tumorigenic potential in mitochondrial DNA-deficient cancer cells
eLife 6:e22187.
https://doi.org/10.7554/eLife.22187

Share this article

https://doi.org/10.7554/eLife.22187

Further reading

    1. Cancer Biology
    2. Immunology and Inflammation
    Sofia V Krasik, Ekaterina A Bryushkova ... Ekaterina O Serebrovskaya
    Research Article

    The current understanding of humoral immune response in cancer patients suggests that tumors may be infiltrated with diffuse B cells of extra-tumoral origin or may develop organized lymphoid structures, where somatic hypermutation and antigen-driven selection occur locally. These processes are believed to be significantly influenced by the tumor microenvironment through secretory factors and biased cell-cell interactions. To explore the manifestation of this influence, we used deep unbiased immunoglobulin profiling and systematically characterized the relationships between B cells in circulation, draining lymph nodes (draining LNs), and tumors in 14 patients with three human cancers. We demonstrated that draining LNs are differentially involved in the interaction with the tumor site, and that significant heterogeneity exists even between different parts of a single lymph node (LN). Next, we confirmed and elaborated upon previous observations regarding intratumoral immunoglobulin heterogeneity. We identified B cell receptor (BCR) clonotypes that were expanded in tumors relative to draining LNs and blood and observed that these tumor-expanded clonotypes were less hypermutated than non-expanded (ubiquitous) clonotypes. Furthermore, we observed a shift in the properties of complementarity-determining region 3 of the BCR heavy chain (CDR-H3) towards less mature and less specific BCR repertoire in tumor-infiltrating B-cells compared to circulating B-cells, which may indicate less stringent control for antibody-producing B cell development in tumor microenvironment (TME). In addition, we found repertoire-level evidence that B-cells may be selected according to their CDR-H3 physicochemical properties before they activate somatic hypermutation (SHM). Altogether, our work outlines a broad picture of the differences in the tumor BCR repertoire relative to non-tumor tissues and points to the unexpected features of the SHM process.

    1. Cancer Biology
    2. Computational and Systems Biology
    Rosalyn W Sayaman, Masaru Miyano ... Mark A LaBarge
    Research Article Updated

    Effects from aging in single cells are heterogenous, whereas at the organ- and tissue-levels aging phenotypes tend to appear as stereotypical changes. The mammary epithelium is a bilayer of two major phenotypically and functionally distinct cell lineages: luminal epithelial and myoepithelial cells. Mammary luminal epithelia exhibit substantial stereotypical changes with age that merit attention because these cells are the putative cells-of-origin for breast cancers. We hypothesize that effects from aging that impinge upon maintenance of lineage fidelity increase susceptibility to cancer initiation. We generated and analyzed transcriptomes from primary luminal epithelial and myoepithelial cells from younger <30 (y)ears old and older >55 y women. In addition to age-dependent directional changes in gene expression, we observed increased transcriptional variance with age that contributed to genome-wide loss of lineage fidelity. Age-dependent variant responses were common to both lineages, whereas directional changes were almost exclusively detected in luminal epithelia and involved altered regulation of chromatin and genome organizers such as SATB1. Epithelial expression variance of gap junction protein GJB6 increased with age, and modulation of GJB6 expression in heterochronous co-cultures revealed that it provided a communication conduit from myoepithelial cells that drove directional change in luminal cells. Age-dependent luminal transcriptomes comprised a prominent signal that could be detected in bulk tissue during aging and transition into cancers. A machine learning classifier based on luminal-specific aging distinguished normal from cancer tissue and was highly predictive of breast cancer subtype. We speculate that luminal epithelia are the ultimate site of integration of the variant responses to aging in their surrounding tissue, and that their emergent phenotype both endows cells with the ability to become cancer-cells-of-origin and represents a biosensor that presages cancer susceptibility.